Natera, Inc. Common Stock NTRA
HEALTHCARE · DIAGNOSTICS & RESEARCHi
Market dataready · fetched 2026-11-12T03:16:13.095Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T23:48:42.819444022Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T03:16:12.462869+00:00
Natera, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 345.09 | 52.6% | 8.7% | 298.14 | 56.9% | 7.9% |
| 25Δ | 339.79 | 52.2% | 7.3% | 302.86 | 56.1% | 6.8% |
| 30Δ | 335.98 | 52.7% | 6.5% | 307.04 | 55.5% | 5.8% |
| 35Δ | 332.17 | 53.2% | 5.7% | 311.03 | 55.0% | 5.0% |
| 40Δ | 328.51 | 53.5% | 4.9% | 314.56 | 54.5% | 4.3% |
| 45Δ | 325.05 | 53.7% | 4.3% | 318.09 | 54.0% | 3.7% |
| 50Δ | 321.59 | 53.8% | 3.7% | 321.57 | 53.6% | 3.1% |
| 55Δ | 318.10 | 54.1% | 3.2% | 325.01 | 53.4% | 2.7% |
| 60Δ | 314.58 | 54.4% | 2.7% | 328.45 | 53.1% | 2.2% |
| 65Δ | 311.07 | 54.7% | 2.2% | 332.14 | 53.0% | 1.8% |
| 70Δ | 307.16 | 55.0% | 1.8% | 336.05 | 52.8% | 1.4% |
| 75Δ | 303.08 | 55.3% | 1.5% | 339.96 | 52.7% | 1.1% |
| 80Δ | 298.63 | 55.7% | 1.1% | 345.48 | 53.4% | 0.8% |
20Δ
- Pseudo strike
- 345.09
- IV
- 52.6%
- B/E move
- 8.7%
- Pseudo strike
- 298.14
- IV
- 56.9%
- B/E move
- 7.9%
25Δ
- Pseudo strike
- 339.79
- IV
- 52.2%
- B/E move
- 7.3%
- Pseudo strike
- 302.86
- IV
- 56.1%
- B/E move
- 6.8%
30Δ
- Pseudo strike
- 335.98
- IV
- 52.7%
- B/E move
- 6.5%
- Pseudo strike
- 307.04
- IV
- 55.5%
- B/E move
- 5.8%
35Δ
- Pseudo strike
- 332.17
- IV
- 53.2%
- B/E move
- 5.7%
- Pseudo strike
- 311.03
- IV
- 55.0%
- B/E move
- 5.0%
40Δ
- Pseudo strike
- 328.51
- IV
- 53.5%
- B/E move
- 4.9%
- Pseudo strike
- 314.56
- IV
- 54.5%
- B/E move
- 4.3%
45Δ
- Pseudo strike
- 325.05
- IV
- 53.7%
- B/E move
- 4.3%
- Pseudo strike
- 318.09
- IV
- 54.0%
- B/E move
- 3.7%
50Δ
- Pseudo strike
- 321.59
- IV
- 53.8%
- B/E move
- 3.7%
- Pseudo strike
- 321.57
- IV
- 53.6%
- B/E move
- 3.1%
55Δ
- Pseudo strike
- 318.10
- IV
- 54.1%
- B/E move
- 3.2%
- Pseudo strike
- 325.01
- IV
- 53.4%
- B/E move
- 2.7%
60Δ
- Pseudo strike
- 314.58
- IV
- 54.4%
- B/E move
- 2.7%
- Pseudo strike
- 328.45
- IV
- 53.1%
- B/E move
- 2.2%
65Δ
- Pseudo strike
- 311.07
- IV
- 54.7%
- B/E move
- 2.2%
- Pseudo strike
- 332.14
- IV
- 53.0%
- B/E move
- 1.8%
70Δ
- Pseudo strike
- 307.16
- IV
- 55.0%
- B/E move
- 1.8%
- Pseudo strike
- 336.05
- IV
- 52.8%
- B/E move
- 1.4%
75Δ
- Pseudo strike
- 303.08
- IV
- 55.3%
- B/E move
- 1.5%
- Pseudo strike
- 339.96
- IV
- 52.7%
- B/E move
- 1.1%
80Δ
- Pseudo strike
- 298.63
- IV
- 55.7%
- B/E move
- 1.1%
- Pseudo strike
- 345.48
- IV
- 53.4%
- B/E move
- 0.8%
Options history
Table
| Date | IV (%) |
|---|---|
| 44.62% | |
| 43.85% | |
| 45.66% | |
| 46.16% | |
| 44.28% | |
| 45.31% | |
| 45.40% | |
| 46.04% | |
| 45.38% | |
| 44.95% | |
| 45.06% | |
| 46.51% | |
| 46.24% | |
| 45.98% | |
| 45.62% | |
| 45.49% | |
| 47.96% | |
| 47.55% | |
| 47.26% | |
| 46.21% | |
| 48.10% | |
| 48.80% | |
| 49.43% | |
| 46.85% | |
| 45.86% | |
| 47.24% | |
| 49.80% | |
| 49.53% | |
| 53.66% | |
| 54.50% | |
| 55.02% | |
| 55.90% | |
| 56.00% | |
| 54.03% | |
| 53.59% | |
| 52.53% | |
| 53.12% | |
| 53.27% | |
| 53.96% | |
| 53.21% | |
| 54.56% | |
| 55.36% | |
| 57.11% | |
| 56.44% | |
| 57.54% | |
| 57.64% | |
| 58.27% | |
| 58.24% | |
| 57.47% | |
| 57.40% | |
| 58.14% | |
| 56.51% | |
| 56.48% | |
| 57.54% | |
| 59.60% |
Diagnostics & Research
OPK
OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and…
More →PSNL
Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.
More →QGEN
QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.
More →RDNT
Description unavailable
More →RVTY
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. The company is headquartered in Waltham,…
More →SHC
Sotera Health Company provides sterilization, laboratory testing, and advisory services to the medical device, pharmaceutical, and food industries in the Americas, Europe, and…
More →